BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11300448)

  • 1. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease.
    Jhund PS; Dawson N; Davie AP; Sattar N; Norrie J; O'Kane KP; McMurray JJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1367-73. PubMed ID: 11300448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women.
    Jhund PS; Dawson N; Davie AP; Norrie J; O'Kane KP; McMurray JJ
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):31-6. PubMed ID: 15115901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease.
    Webb CM; Ghatei MA; McNeill JG; Collins P
    Circulation; 2000 Oct; 102(14):1617-22. PubMed ID: 11015337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Tsuda M; Nagai N; Ohama K
    J Am Coll Cardiol; 2001 May; 37(6):1529-35. PubMed ID: 11345361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute vascular effects of estrogen in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Circulation; 1994 Aug; 90(2):786-91. PubMed ID: 8044949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estrogen therapy and aerobic training on sympathetic activity and hemodynamics in healthy postmenopausal women: a double-blind randomized trial.
    Oneda B; Cardoso CG; Forjaz CL; Araújo TG; Bernardo FR; de Gusmão JL; Pinto LG; Labes E; Abrahão SB; Mion D; Fonseca AM; Tinucci T
    Menopause; 2014 Apr; 21(4):369-75. PubMed ID: 23899829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women.
    Oneda B; Forjaz CL; Bernardo FR; Araújo TG; Gusmão JL; Labes E; Abrahão SB; Mion D; Fonseca AM; Tinucci T
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1802-8. PubMed ID: 18775846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
    N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.
    Hodis HN; Mack WJ; Azen SP; Lobo RA; Shoupe D; Mahrer PR; Faxon DP; Cashin-Hemphill L; Sanmarco ME; French WJ; Shook TL; Gaarder TD; Mehra AO; Rabbani R; Sevanian A; Shil AB; Torres M; Vogelbach KH; Selzer RH;
    N Engl J Med; 2003 Aug; 349(6):535-45. PubMed ID: 12904518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of 17beta-estradiol over 3 months without progestin co-administration does not improve coronary flow reserve in post-menopausal women: a randomized placebo-controlled cross-over CMR study.
    Schwitter J; Kozerke S; Bremerich J; Baltes C; Attenhofer Jost C; Birkhäuser M; Boesiger P; Buser P
    J Cardiovasc Magn Reson; 2007; 9(4):665-72. PubMed ID: 17578722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen acutely increases peripheral blood flow in postmenopausal women.
    Volterrani M; Rosano G; Coats A; Beale C; Collins P
    Am J Med; 1995 Aug; 99(2):119-22. PubMed ID: 7625415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women.
    Sudhir K; Elser MD; Jennings GL; Komesaroff PA
    Hypertension; 1997 Dec; 30(6):1538-43. PubMed ID: 9403579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
    Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
    Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
    Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.